Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1,217,014
-
Shares change
-
-1,694,847
-
Total reported value, excl. options
-
$1,287,936
-
Value change
-
-$1,765,451
-
Put/Call ratio
-
25%
-
Number of buys
-
12
-
Number of sells
-
12
-
Price
-
$1.06
Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q1 2022
As of 31 Mar 2022 Protalix BioTherapeutics, Inc. - COM (PLX) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,217,014 shares of stock of the company.
Largest 10 holders included MEITAV DASH INVESTMENTS LTD, Phoenix Holdings Ltd., Spire Wealth Management, JANE STREET GROUP, LLC, BlackRock Inc., TWO SIGMA ADVISERS, LP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, GROUP ONE TRADING, L.P., BRIDGEWAY CAPITAL MANAGEMENT, LLC, and IHT Wealth Management, LLC.
This table shows 28 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.